全文获取类型
收费全文 | 43134篇 |
免费 | 3151篇 |
国内免费 | 1906篇 |
专业分类
耳鼻咽喉 | 321篇 |
儿科学 | 369篇 |
妇产科学 | 544篇 |
基础医学 | 2660篇 |
口腔科学 | 866篇 |
临床医学 | 3434篇 |
内科学 | 3591篇 |
皮肤病学 | 822篇 |
神经病学 | 1677篇 |
特种医学 | 968篇 |
外国民族医学 | 7篇 |
外科学 | 2577篇 |
综合类 | 7302篇 |
现状与发展 | 6篇 |
预防医学 | 2059篇 |
眼科学 | 1214篇 |
药学 | 14025篇 |
49篇 | |
中国医学 | 4773篇 |
肿瘤学 | 927篇 |
出版年
2024年 | 96篇 |
2023年 | 421篇 |
2022年 | 905篇 |
2021年 | 1423篇 |
2020年 | 1228篇 |
2019年 | 1081篇 |
2018年 | 1238篇 |
2017年 | 1363篇 |
2016年 | 1530篇 |
2015年 | 1421篇 |
2014年 | 3043篇 |
2013年 | 3215篇 |
2012年 | 3163篇 |
2011年 | 3316篇 |
2010年 | 2543篇 |
2009年 | 2185篇 |
2008年 | 2084篇 |
2007年 | 2161篇 |
2006年 | 1970篇 |
2005年 | 1728篇 |
2004年 | 1427篇 |
2003年 | 1268篇 |
2002年 | 1066篇 |
2001年 | 893篇 |
2000年 | 714篇 |
1999年 | 629篇 |
1998年 | 535篇 |
1997年 | 495篇 |
1996年 | 474篇 |
1995年 | 412篇 |
1994年 | 388篇 |
1993年 | 322篇 |
1992年 | 245篇 |
1991年 | 269篇 |
1990年 | 267篇 |
1989年 | 236篇 |
1988年 | 214篇 |
1987年 | 159篇 |
1986年 | 151篇 |
1985年 | 356篇 |
1984年 | 271篇 |
1983年 | 232篇 |
1982年 | 216篇 |
1981年 | 216篇 |
1980年 | 151篇 |
1979年 | 112篇 |
1978年 | 96篇 |
1977年 | 65篇 |
1976年 | 60篇 |
1975年 | 51篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
曾艺东 《白求恩军医学院学报》2005,3(3):137-138
目的观察喜炎平与维生素K3联合治疗小儿秋季腹泻的疗效.方法将89例秋季腹泻患儿随机分为2组.治疗组采用喜炎平与维生素K3联合治疗,对照组则采用利巴韦林治疗,疗程5d.结果治疗组的总有效率为93.3%,显著优于对照组的65.9%(X2=10.37,P<0.01).结论喜炎平与维生素K3联合治疗小儿秋季腹泻值得进一步推广. 相似文献
52.
黄芪、小柴胡冲剂联合辅酶Q10治疗病毒性心肌炎 总被引:1,自引:0,他引:1
目的观察黄芪、小柴胡冲剂联合辅酶Q10治疗病毒性心肌炎(VMC)的临床疗效.方法治疗组(30例)应用黄芪注射液、小柴胡冲剂和辅酶Q10;对照组(30例)用GIK极化液、辅酶Q10和维生素C,两组患者无禁忌证者均给予β-受体阻滞剂,钙拮抗剂和对症治疗.两组疗程均为3个月.结果治疗组临床症状和心律失常总有效率分别为73.3%和86.6%,高于对照组的43.3%和63.3%(p<0.05).结论黄芪、小柴胡冲剂联合辅酶Q10对VMC有较好疗效,且无明显不良反应. 相似文献
53.
钠摄入量对心力衰竭大鼠心脏肾素-血管紧张素系统与心钠素的影响 总被引:7,自引:1,他引:6
目的 观察钠摄入量对心力衰竭大鼠心脏局部肾素-血管紧张素系统与心钠素的影响 .方法 经动 -静脉分流术造成大鼠充血性心衰模型 ,分为心衰组、心衰限钠组、心衰补钠组 ,假手术大鼠为对照组 ,用放射免疫分析法和原位杂交技术分别测定各组血浆和心肌血管紧张素 、心钠素含量及心肌血管紧张素原 m RNA表达水平 (吸光度 A值 ) ,同时检测心功能 .结果 心衰限钠组心房和心室血管紧张素 含量(2 0 .1± 4 .5 )和 (2 7.3± 5 .9) ng· g- 1、血管紧张素原 m RNA表达 (6 .4± 1.2 )和 (12 .6± 2 .3)显著高于心衰组 (17.5± 3.6 )和 (2 0 .1± 3.7) ng· g- 1 ,(6 .2± 1.9)和 (8.6± 1.7) (P<0 .0 5 ,P<0 .0 1) ,心室心钠素 (42 3± 6 8) ng· g- 1 也显著高于心衰组 (337± 86 ) ng· g- 1 (P<0 .0 5 ) ,心房心钠素 (6 7± 19)μg· g- 1显著低于心衰组 (85± 15 ) μg· g- 1 (P<0 .0 5 ) ;心衰补钠组心房和心室血管紧张素原 m RNA表达水平、心室血管紧张素 和心钠素与心衰组无显著差别 ,心房血管紧张素 与对照组无显著差别 ,心房心钠素 (10 1± 17) μg· g- 1 显著高于心衰组 (P<0 .0 1) .结论 心衰时不同钠摄入量可通过改变心脏局部肾素 -血管紧张素系统与心钠素的平衡状态在心衰发展进程中发挥作用 相似文献
54.
L. Rosenberg M.D. I. T. Jackson D. Sharpe J. Weiss 《European journal of plastic surgery》1987,9(4):158-159
Summary A system which can be used for injection or infiltration of large volumes of fluid is described. This consists of a syringe which fills automatically from a reservoir through an inlet/outlet valve. 相似文献
55.
Devi Kanikanti Padmalatha Rao Kanikanti V. Ranga Baveja Srikrishan Fathi Marc Roth Marc 《Pharmaceutical research》1989,6(4):313-317
Zero-order release of oxprenolol hydrochloride was obtained by controlling the swelling and erosion of the matrix. This formulation involves only mixing of drug, hydroxypropylmethylcellulose (HPMC), and sodium carboxymethylcellulose (Na CMC) at the ratio of 1:0.4:1.6, respectively, and compressing the mixture directly into tablets. The in vitro release pattern from this optimized matrix tablet was reproducible. Accelerated stability studies revealed that the optimized formulation remains stable for an approximately 2-year shelf life. This sustained-release (SR) tablet was evaluated in dogs, and for comparison a conventional (CV) formulation was also given at the same dose level. Plasma oxprenolol levels were monitored by a sensitive and specific high-performance liquid chromatographic (HPLC) method. Significant differences in the pharmacokinetic parameters, i.e., lower C
max, higher values of t
max, MRT, AUC, and plasma concentration at 24 hr, and nearly constant plasma levels over 12 hr, indicated that the SR matrix tablet is superior to the CV rapid-releasing formulation. The in vitro release parameters and in vivo pharmacokinetics correlated well. 相似文献
56.
57.
Lü Zhuo-ren 《中国人民解放军军医大学学报》2006,21(5)
Objective: To compare renal sodium transport, using fractional excretions of lithium(FELi) as a marker of proximal tubule sodium reabsorption, between hypertensive and non-hypertensive ouabain-treated rats and further to elucidate the role of ouabain in pathogenesis of hypertension. Methods: Thirty male Sprague-Dawley rats weighting 180-200 g were randomly divided into normal control group and ouabain treated group. Rats were infused with 1 ml/kg·d normal saline or 27. 8μg/kg·d ouabain in-traperitoneally once a day respectively. Systolic blood pressure (SBP), heart rate and body weight were recorded weekly. Rats were sacrificed 6 weeks after treatment. Blood and 24-hour urine sample were collected to measure the serum and urinary concentration of sodium, trace lithium and creatinine. Endogenous creatinine clearance rate(Ccr), fractional excretions of sodium (FENa), fractional excretions of lithium (FELi) and fractional reabsorption of sodium in the postproximal tubules (FDRNa) were calculated. Ouabain levels of plasma and renal tissue, plasma renin activity, angiotensin I and aldosterone concentration were determined. Results: 65% of the ouabain-treated rats achieved significantly higher SBP after 4 weeks, compared with that of the saline control groups or self baseline (P<0. 01). But in the other 35% of the ouabain-treated rats, their SBP was similar with control group during the experiment (P>0. 05). The body weight, heart rate and food intake between the 3 groups were no significant differences (P> 0. 05). FELi and FDRNa were significantly lower in ouabain-hypertensive group compared with ouabain-non-hypertensive group and control group(P<0. 01 and P<0. 05). The FEu and FDRn, of ouabain-nonhyper-tensive groups were similar with control group(P>0. 05). Ccr and FENa were comparable between the 3 groups (P>0. 05). Plasma and renal tissue ouabain levels, plasma renin activity, angiotensin I and aldosterone contents in ouabain-hypertensive rats were comparable with ouabain-nonhypertensive rats. Conclusion: Increase of proximal tubule sodium reabsorption play an important role in the pathogenesis of ouabain-hypertensive rats. The change of renal sodium transport may result from regulation to renal Na+ , K + -ATPase by ouabain. 相似文献
58.
F. Njaa T. Baekken D. Bjaamer J. I. Holme F. Korsrud O. Woxen A. K. Olsen 《Pediatric allergy and immunology》1992,3(1):39-42
Fifty–five children 6–16 years old with allergic rhinoconjunctivitis due to both birch and grass pollinosis were randomized into 2 parallel groups, treated in double–blind fashion with either levocabastinc (LEV) eye–drops twice daily plus placebo eyedrops twice daily or sodium cromoglycate (SCG) eyedrops 4 times daily for 3 months. Spersallerg® (antazolini chloride + tetryzolini chloride) eyedrops were allowed as rescue medicine. All children received basic treatment with an antihistamine (terfenadine) during the complete trial period, and a local nasal corticosteroid if needed. Eye symptoms were recorded daily by the patients and at 4 visits by the investigator, at start and after 4, 10 and 13 weeks. Pollen counts were performed and a blood sample was collected at start and end of the treatment. The global evaluation of treatment was similar for the 2 groups, and there was no significant difference in any effect parameter except for the symptom, itchy eyes, which had lower score in the SCG group as evaluated by the investigator after 4 weeks. On days with low pollen counts the patients in the SCG group had fewer days with moderate or severe eye symptoms. It is concluded that even though LEV and SCG eyedrops were given in addition to systemic treatment with an antihistamine, no consistently significant differences in clinical effect were found between the 2 treatment groups, but the SCG group experienced slightly less eye symptoms throughout the trial. LEV eye–drops appear safe in long–term treatment in children, and no signs of tachyphylaxis were recorded. 相似文献
59.
目的 观察穴位注射丹参合并小剂量抗精神病药物与单用抗精神病药物治疗精神分裂症的疗效。方法16 0例患者随机分为治疗组 10 0例 ,对照组 6 0例 ;辨证分为 5型 ,用阴阳经相配取穴的方法 ,根据疾病的虚实 ,用迎随和徐疾补泻手法 ,治疗组每日注射 1次 ,10次为 1疗程 ,共治疗 3个疗程 ;用简明精神症状量表 (BPRS)和药物副反应量表 (TESS)评定疗效和副反应 ,治疗结束后随访两年。结果 治疗组痊愈率、显效率与对照组间差异有显著性意义 (P <0 0 5 )。BPRS和TESS量表于每疗程结束后两组评分比较差异均有显著性意义 (P <0 0 5 ) ;复发率与对照组间差异有显著性意义 (P <0 0 5 )。结论 穴位注射丹参具有见效快、副作用少、远期疗效好的特点。实施有效的护理 ,适时的健康教育是提高患者依从性 ,保证有效治疗、取得良好效果的重要手段。 相似文献
60.
目的 探讨参麦注射液对冠心病 (CHD)心绞痛的治疗作用。方法 80例患者分为两组 ,每组 4 0例 ,在常规治疗的基础上 ,对照组应用丹参注射液进行治疗 ,治疗组应用参麦注射液进行治疗。结果 治疗组有效 39例 (97.5 % ) ,心电图改善 38例 (95 .0 % ) ,对照组分别为 31例 (77.5 % )和 2 9例 (72 .5 % ) ,组间比较具有显著性差异 (P <0 .0 1)。结论 参麦注射液对冠心病心绞痛疗效显著 ,且安全、无明显副作用 相似文献